Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2663-2671

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aldo Del Maschio
Right arrow Articles by Dejana, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldo Del Maschio,
Right arrow Articles by Dejana, E.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2663-2671.)
© 1997 American Heart Association, Inc.

Articles

Triggering of ß1-Integrin Chain Induces Platelet Adhesion to Cultured Endothelium

Aldo Del Maschio; Inés Martín-Padura; Sergio Bernasconi; ; Elisabetta Dejana

From the Laboratory of Vascular Biology and Human Immunology, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Correspondence to Aldo Del Maschio, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy. E-mail delmaschio{at}irfmn.mnegri.it

Abstract We report here that platelets adhere to cultured endothelial cells (EC) on exposure to the integrin ß1 activating monoclonal antibody (mAb) BV7. The effect of BV7 is exerted mostly on platelets rather than EC. BV7 does not induce platelet aggregation or 5-hydroxytyptamine (5-HT) release and does not increase platelet adhesion to matrix proteins. Another activating ß1 mAb, Lia1/2, triggers an effect similar to BV7. Blocking antibodies to {alpha}2 and ß1, but not to other integrin chains, are able to inhibit BV7-mediated adhesion. Moreover, the effect of BV7 requires active cellular metabolism and is not inhibited by platelet treatment with aspirin, by the PAF receptor antagonist BN50730, the phosphokinase C inhibitor staurosporin, or by the cAMP or cGMP enhancers prostaglandin E1 and sodium nitroprusside, respectively. Finally, BV7-mediated adhesion was enhanced by the endoperoxide analogue U46619. These data describe a novel mechanism of platelet adhesion to endothelial cells. This adhesion pathway appears to be mediated by {alpha}2ß1-integrin on platelets and a still-undefined endothelial counter receptor.


Key Words: platelets • endothelial cells • integrins • adhesion






ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.